Proposed FDA Framework for Importation Requires Cooperation from Manufacturers, Raising Questions of Impact

The Food and Drug Administration (FDA) has released their long-awaited proposed rule on prescription drug importation. President Trump has mentioned his plan at events in recent months, citing the plan as part of the administration’s efforts to lower prescription drug costs. The proposed rule outlines requirements for so-called Section 804 Importation Programs (SIPs), named after [...] Read More